Allaying and alleviating amyloid agony and anxiety.

Research output: Contribution to journalComment/debate

4 Citations (Scopus)

Abstract

In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.

Original languageEnglish (US)
Pages (from-to)3301-3302
Number of pages2
JournalBlood
Volume121
Issue number17
DOIs
StatePublished - Apr 25 2013

Fingerprint

Blood pressure
Amyloid
Blood
Anxiety
Blood Pressure
Amyloidosis

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Allaying and alleviating amyloid agony and anxiety. / Gertz, Morie.

In: Blood, Vol. 121, No. 17, 25.04.2013, p. 3301-3302.

Research output: Contribution to journalComment/debate

Gertz, Morie. / Allaying and alleviating amyloid agony and anxiety. In: Blood. 2013 ; Vol. 121, No. 17. pp. 3301-3302.
@article{68ccf95a17c84c86bd65c1b5f13fcd15,
title = "Allaying and alleviating amyloid agony and anxiety.",
abstract = "In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.",
author = "Morie Gertz",
year = "2013",
month = "4",
day = "25",
doi = "10.1182/blood-2013-03-491746",
language = "English (US)",
volume = "121",
pages = "3301--3302",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "17",

}

TY - JOUR

T1 - Allaying and alleviating amyloid agony and anxiety.

AU - Gertz, Morie

PY - 2013/4/25

Y1 - 2013/4/25

N2 - In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.

AB - In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.

UR - http://www.scopus.com/inward/record.url?scp=84879454197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879454197&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-03-491746

DO - 10.1182/blood-2013-03-491746

M3 - Comment/debate

VL - 121

SP - 3301

EP - 3302

JO - Blood

JF - Blood

SN - 0006-4971

IS - 17

ER -